Lv61
3040 积分 2023-10-21 加入
Association of the metabolic dysfunction-associated steatotic liver disease with cardiovascular and kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study
5小时前
已完结
Low-Plasma Insulin-Like Growth Factor-1 Associates With Increased Mortality in Chronic Kidney Disease Patients With Reduced Muscle Strength
7小时前
已完结
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
1个月前
已完结
Growth Hormone, Insulin-Like Growth Factor-1, and the Kidney: Pathophysiological and Clinical Implications
2个月前
已完结
Unexpected role for IGF-1 in starvation: Maintenance of blood glucose
3个月前
已完结
Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis
3个月前
已完结
Growth Hormone Control of Hepatic Lipid Metabolism
3个月前
已完结
Higher Circulating Alpha-Klotho Levels Increase All-Cause Mortality Through Mediation Effects of Liver Fibrosis: A Second Analysis of NHANES
3个月前
已完结
Potential Role of Growth Factors With Particular Focus on Growth Hormone and Insulin-Like Growth Factor-1 in the Management of Chronic Kidney Disease
4个月前
已完结
Association between circulating insulin-like growth factor 1 and risk of all-cause and cause-specific mortality
5个月前
已完结
皖公网安备34019202002308
